Atrás
Rango del Día
$468.50
$480.18
Rango de 52 Semanas
$425.00
$603.88
Volumen
1,426,703
Promedio 50D / 200D
$505.85
/
$509.44
Cierre Anterior
$471.91
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 58.4 | 0.2 |
| P/B | 9.4 | 3.0 |
| ROE % | 16.7 | 3.6 |
| Net Margin % | 28.4 | 3.8 |
| Rev Growth 5Y % | 15.2 | 9.9 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$638.75
+35.9%
Low: $550.00
High: $750.00
P/E Futuro
46.78
EPS Futuro
$10.05
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
11.52B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$16.55
$15.60 – $17.75
|
18.89B | 5 |
| FY2029 |
$15.13
$14.26 – $16.23
|
17.23B | 2 |
| FY2028 |
$13.22
$12.29 – $14.32
|
15.01B | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-22 | $2.27 | $2.53 | +11.5% |
| 2025-10-21 | $1.99 | $2.40 | +20.6% |
| 2025-07-22 | $1.93 | $2.19 | +13.5% |
| 2025-04-22 | $1.74 | $1.81 | +4.0% |
| 2025-01-23 | $1.76 | $2.21 | +25.6% |
| 2024-10-17 | $1.63 | $1.84 | +12.9% |
| 2024-07-18 | $1.54 | $1.78 | +15.6% |
| 2024-04-18 | $1.41 | $1.50 | +6.4% |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 28, 2026 |
Samath Jamie
EVP & CFO & Enterprise Technol
|
other | 28,766 | — | — |
| Jan 29, 2026 |
Leonard Keith R
Director
|
other | 369 | — | — |
| Dec 15, 2025 |
Brosius Mark
See Remarks
|
sell | 464 | $548.49 | $254,499.36 |
| Dec 12, 2025 |
Brosius Mark
See Remarks
|
sell | 312 | $547.36 | $170,776.32 |
| Dec 10, 2025 |
Curet Myriam
EVP & Chief Medical Officer
|
other | 208 | $229.39 | — |
| Dec 10, 2025 |
Curet Myriam
EVP & Chief Medical Officer
|
sell | 104 | $559.90 | $58,229.60 |
| Nov 12, 2025 |
BARRATT CRAIG H
Director
|
other | 1,500 | $71.32 | — |
| Nov 12, 2025 |
BARRATT CRAIG H
Director
|
sell | 750 | $580.00 | $435,000.00 |
| Nov 12, 2025 |
Leonard Keith R
Director
|
other | 1,606 | — | — |
| Sep 4, 2025 |
Ladd Amy L
Director
|
sell | 335 | $440.69 | $147,631.15 |
| Sep 3, 2025 |
Ladd Amy L
Director
|
sell | 336 | $470.11 | $157,956.96 |
| Jun 4, 2025 |
Rosa David J.
President
|
other | 851 | — | — |
| May 16, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 20 | $563.81 | $11,276.20 |
| May 15, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 22 | $560.00 | $12,320.00 |
| May 14, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 22 | $563.00 | $12,386.00 |
| May 13, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 22 | $561.67 | $12,356.74 |
| May 12, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 22 | $551.97 | $12,143.34 |
| May 1, 2025 |
Leonard Keith R
Director
|
grant | 531 | — | — |
| May 1, 2025 |
NACHTSHEIM JAMI K
Director
|
other | 4,800 | $90.49 | — |
| May 1, 2025 |
NACHTSHEIM JAMI K
Director
|
sell | 2,400 | $520.00 | $1,248,000.00 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Revenue grew 15.22% annually over 5 years — strong growth
Earnings grew 22.97% over the past year
ROE of 16.67% — decent returns on equity
Net margin of 28.38% shows strong profitability
Debt/Equity of 0.02 — conservative balance sheet
Generating 2.49B in free cash flow
Crecimiento
Revenue Growth (5Y)
15.22%
Revenue (1Y)20.51%
Earnings (1Y)22.97%
FCF Growth (3Y)82.28%
Calidad
Return on Equity
16.67%
ROIC12.19%
Net Margin28.38%
Op. Margin29.27%
Seguridad
Debt / Equity
0.02
Current Ratio4.87
Interest Coverage0.00
Valoración
P/E Ratio
58.44
Forward P/E46.78
P/B Ratio9.36
EV/EBITDA55.62
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.51% | Revenue Growth (3Y) | 18.86% |
| Earnings Growth (1Y) | 22.97% | Earnings Growth (3Y) | 26.03% |
| Revenue Growth (5Y) | 15.22% | Earnings Growth (5Y) | 13.77% |
| Profitability | |||
| Revenue (TTM) | 10.06B | Net Income (TTM) | 2.86B |
| ROE | 16.67% | ROA | 13.84% |
| Gross Margin | 66.00% | Operating Margin | 29.27% |
| Net Margin | 28.38% | Free Cash Flow (TTM) | 2.49B |
| ROIC | 12.19% | FCF Growth (3Y) | 82.28% |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 4.87 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 58.44 | Forward P/E | 46.78 |
| P/B Ratio | 9.36 | P/S Ratio | 16.58 |
| PEG Ratio | 3.17 | Forward PEG | N/A |
| EV/EBITDA | 55.62 | Fwd EV/EBITDA | 42.15 |
| Forward P/S | 14.48 | Fwd Earnings Yield | 2.14% |
| FCF Yield | 1.49% | ||
| Market Cap | 166.90B | Enterprise Value | 163.84B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.06B | 8.35B | 7.12B | 6.22B | 5.71B |
| Net Income | 2.86B | 2.32B | 1.80B | 1.32B | 1.70B |
| EPS (Diluted) | 7.87 | 6.42 | 5.03 | 3.65 | 4.66 |
| Gross Profit | 6.64B | 5.63B | 4.73B | 4.20B | 3.96B |
| Operating Income | 2.95B | 2.35B | 1.77B | 1.58B | 1.82B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 20.63B | 18.84B | 15.44B | 12.97B | 13.56B |
| Total Liabilities | 2.69B | 2.31B | 2.04B | 1.86B | 1.60B |
| Shareholders' Equity | 17.82B | 16.43B | 13.31B | 11.04B | 11.95B |
| Total Debt | 302.80M | 146.00M | 0.0 | 0.0 | 87.00M |
| Cash & Equivalents | 3.37B | 2.03B | 2.75B | 1.58B | 1.29B |
| Current Assets | 9.78B | 7.11B | 7.89B | 6.25B | 5.84B |
| Current Liabilities | 2.01B | 1.75B | 1.66B | 1.42B | 1.15B |